The Hydration Pharmaceuticals Company Limited (ASX:HPC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0090
0.00 (0.00%)
Jun 4, 2025, 11:50 AM AEST

ASX:HPC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
2.67-8.1-10.61-8.95-0.74
Upgrade
Depreciation & Amortization
---00.02
Upgrade
Other Amortization
---0.32-
Upgrade
Loss (Gain) From Sale of Assets
--0.03--2.75
Upgrade
Other Operating Activities
-7.621.792.12.530.23
Upgrade
Change in Accounts Receivable
1.4-0.44-0.29-0.24-0.19
Upgrade
Change in Inventory
0.860.85-1.72-0.21-0.72
Upgrade
Change in Accounts Payable
-1.420.170.07-0.130.67
Upgrade
Change in Other Net Operating Assets
0.24-00.67-1.4-0.38
Upgrade
Operating Cash Flow
-3.88-5.73-9.75-8.08-3.86
Upgrade
Capital Expenditures
-----0.02
Upgrade
Sale of Property, Plant & Equipment
9.44----
Upgrade
Sale (Purchase) of Intangibles
----2.75
Upgrade
Investing Cash Flow
9.44---2.73
Upgrade
Long-Term Debt Issued
1.110.254.08--
Upgrade
Long-Term Debt Repaid
-5.15----
Upgrade
Net Debt Issued (Repaid)
-4.040.254.08--
Upgrade
Issuance of Common Stock
-2.7-18.45-
Upgrade
Other Financing Activities
-0.02-0.24--1.42-
Upgrade
Financing Cash Flow
-4.072.724.0817.03-
Upgrade
Foreign Exchange Rate Adjustments
-0.120.17-0.310.080.04
Upgrade
Net Cash Flow
1.38-2.85-5.989.03-1.09
Upgrade
Free Cash Flow
-3.88-5.73-9.75-8.08-3.88
Upgrade
Free Cash Flow Margin
-121.03%-133.22%-107.16%-131.84%-103.29%
Upgrade
Free Cash Flow Per Share
-0.01-0.03-0.06-0.11-0.06
Upgrade
Cash Interest Paid
0.690.53--0.01
Upgrade
Levered Free Cash Flow
-1.18-2.35-5.48-6.340.09
Upgrade
Unlevered Free Cash Flow
-0.08-1.95-5.43-4.750.1
Upgrade
Change in Net Working Capital
-2.17-1.310.452.20.67
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.